A42.8 Other forms of actinomycosis

Name of the Condition

• Other forms of actinomycosis

Summary

Other forms of actinomycosis represent chronic bacterial infections caused by Actinomyces species, resulting in granulomatous inflammation and abscess formation in sites beyond the cervicofacial, thoracic, or abdominal regions. These infections progress slowly and may involve adjacent tissues if untreated, with potential for tissue destruction.

Causes

Other forms of actinomycosis are caused by anaerobic or microaerophilic bacteria from the genus Actinomyces, most commonly Actinomyces israelii. These bacteria are part of the normal flora in the mouth, gastrointestinal tract, and other mucosal surfaces but can invade tissues due to trauma, surgery, or other disruptions.

Risk Factors

• Trauma to non-traditional sites (e.g., skin, bones, or soft tissues)
• Surgical procedures involving non-abdominal or non-thoracic areas
• Immunocompromised states (e.g., diabetes, HIV)
• Chronic infections or fistulas in atypical locations
• Foreign bodies or implants in unusual sites
• Poor wound care or delayed healing

Symptoms

• Slow-growing, firm, or fluctuant masses in atypical locations
• Draining sinus tracts with sulfur granules
• Localized pain, swelling, or tenderness
• Fever or systemic symptoms
• Tissue destruction or fistula formation
• Functional impairment related to the affected area

Diagnosis

Diagnosis is based on clinical presentation, imaging (e.g., MRI or CT showing abscesses or fistulas in non-standard sites), and microbiological confirmation (e.g., tissue culture identifying Actinomyces species). Biopsy may be required to rule out other conditions.

Treatment Options

• Long-term antibiotic therapy (e.g., penicillin or doxycycline)
• Surgical drainage or debridement of abscesses
• Removal of foreign bodies or infected tissue
• Supportive care for pain or systemic symptoms
• Monitoring for treatment response

Prognosis and Follow-Up

Prognosis is generally good with appropriate treatment, though recovery may be prolonged. Follow-up includes monitoring for recurrence, assessing treatment efficacy, and addressing any residual tissue damage. Immunocompromised patients may require extended therapy.

Complications

• Chronic infection or recurrence
• Tissue destruction or functional impairment
• Spread to adjacent structures
• Delayed diagnosis due to atypical presentation
• Resistance to initial antibiotic therapy

Lifestyle & Prevention

• Maintain good wound care and hygiene
• Address underlying trauma or surgical sites promptly
• Manage immunocompromising conditions effectively
• Seek early evaluation for persistent or unusual infections
• Follow post-procedure care instructions to reduce infection risk

When to Seek Professional Help

• Persistent or worsening symptoms (e.g., pain, swelling, or drainage)
• Signs of systemic infection (e.g., fever, chills)
• New or unexplained masses or fistulas
• Delayed healing of wounds or surgical sites
• Concerns about treatment response or recurrence

Tips for Medical Coders

Document the specific site of infection (e.g., skin, bone, or other atypical location) and any associated complications. Ensure clinical details support the diagnosis and differentiate from other actinomycosis forms. Include information on diagnostic methods (e.g., imaging, culture) and treatment approaches for accurate coding.